The Duke Cancer Institute's experienced physicians focus on diagnosing and treating urologic cancers while preserving normal function.
Over eight decades of experience in caring for patients with urologic diseases has established Duke as a world leader in urologic care, research, and education. In 2011, Duke was ranked #8 in America by U.S.News & World Report for urologic services.
The urologic cancer program at the Duke Cancer Institute provides expert treatment for cancers of the:
Often, patients can be treated with minimally invasive surgery.
The Duke Cancer Institute employs a team approach to the prevention and treatment of prostate and other genitourinary cancers.
A multidisciplinary team of urologists, surgical oncologists, medical oncologists, and radiation oncologists work closely to treat urologic cancers. We work individually with each patient to create a care plan that aggressively fights their cancer while maintaining a high quality of life and minimizing negative treatment effects.
Together, caregivers provide information and consultation at the time of diagnosis, providing state-of-the-art treatment options in urology, radiation oncology, and medical oncology, as well as new treatments based on basic, translational, and clinical research.
Novel treatments are available through a robust clinical trials program.
The Duke Cancer Institute also provides many support services to enhance patient quality of life, provide resources to manage cancer-related symptoms, and improve the experience of having cancer while ensuring that patients receive high quality medical treatment.
Learn how to make an appointment at the Duke Cancer Institute.